45 related articles for article (PubMed ID: 15799867)
1. Preparation of the hypoxia imaging PET tracer [18F]FAZA: reaction parameters and automation.
Reischl G; Ehrlichmann W; Bieg C; Solbach C; Kumar P; Wiebe LI; Machulla HJ
Appl Radiat Isot; 2005 Jun; 62(6):897-901. PubMed ID: 15799867
[TBL] [Abstract][Full Text] [Related]
2. Significant impact of different oxygen breathing conditions on noninvasive in vivo tumor-hypoxia imaging using [¹⁸F]-fluoro-azomycinarabino-furanoside ([¹⁸F]FAZA).
Maier FC; Kneilling M; Reischl G; Cay F; Bukala D; Schmid A; Judenhofer MS; Röcken M; Machulla HJ; Pichler BJ
Radiat Oncol; 2011 Nov; 6():165. PubMed ID: 22118419
[TBL] [Abstract][Full Text] [Related]
3. Concomitant [
Kepes Z; Hegedus E; Sass T; Csikos C; Szabo JP; Szugyiczki V; Hajdu I; Kertesz I; Opposits G; Imrek J; Balkay L; Kalman FK; Trencsenyi G
In Vivo; 2024; 38(2):574-586. PubMed ID: 38418132
[TBL] [Abstract][Full Text] [Related]
4. Advances in PET imaging of cancer.
Schwenck J; Sonanini D; Cotton JM; Rammensee HG; la Fougère C; Zender L; Pichler BJ
Nat Rev Cancer; 2023 Jul; 23(7):474-490. PubMed ID: 37258875
[TBL] [Abstract][Full Text] [Related]
5. Fluorinated carbohydrates for
Campbell E; Jordan C; Gilmour R
Chem Soc Rev; 2023 Jun; 52(11):3599-3626. PubMed ID: 37171037
[TBL] [Abstract][Full Text] [Related]
6. Scandium-44: Diagnostic Feasibility in Tumor-Related Angiogenesis.
Trencsényi G; Képes Z
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108559
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, Physicochemical, Labeling and In Vivo Characterization of
Szücs D; Csupász T; Szabó JP; Kis A; Gyuricza B; Arató V; Forgács V; Vágner A; Nagy G; Garai I; Szikra D; Tóth I; Trencsényi G; Tircsó G; Fekete A
Pharmaceuticals (Basel); 2022 May; 15(6):. PubMed ID: 35745585
[TBL] [Abstract][Full Text] [Related]
8. Refinement of an Established Procedure and Its Application for Identification of Hypoxia in Prostate Cancer Xenografts.
Elming PB; Wittenborn TR; Busk M; Sørensen BS; Thomsen MBH; Strandgaard T; Dyrskjøt L; Nielsen S; Horsman MR
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34073301
[TBL] [Abstract][Full Text] [Related]
9. Mechanism-Specific Pharmacodynamics of a Novel Complex-I Inhibitor Quantified by Imaging Reversal of Consumptive Hypoxia with [
Gammon ST; Pisaneschi F; Bandi ML; Smith MG; Sun Y; Rao Y; Muller F; Wong F; De Groot J; Ackroyd J; Mawlawi O; Davies MA; Gopal YNV; Di Francesco ME; Marszalek JR; Dewhirst M; Piwnica-Worms D
Cells; 2019 Nov; 8(12):. PubMed ID: 31766580
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia imaging with
Melsens E; De Vlieghere E; Descamps B; Vanhove C; Kersemans K; De Vos F; Goethals I; Brans B; De Wever O; Ceelen W; Pattyn P
Radiat Oncol; 2018 Mar; 13(1):39. PubMed ID: 29514673
[TBL] [Abstract][Full Text] [Related]
11. The Molecular Industrial Revolution: Automated Synthesis of Small Molecules.
Trobe M; Burke MD
Angew Chem Int Ed Engl; 2018 Apr; 57(16):4192-4214. PubMed ID: 29513400
[TBL] [Abstract][Full Text] [Related]
12. Quantitative and qualitative analysis of [(18)F]FDG and [(18)F]FAZA positron emission tomography of head and neck cancers and associations with HPV status and treatment outcome.
Graves EE; Hicks RJ; Binns D; Bressel M; Le QT; Peters L; Young RJ; Rischin D
Eur J Nucl Med Mol Imaging; 2016 Apr; 43(4):617-25. PubMed ID: 26577940
[TBL] [Abstract][Full Text] [Related]
13. Detecting functional changes with [(18)F]FAZA in a renal cell carcinoma mouse model following sunitinib therapy.
Chapman DW; Jans HS; Ma I; Mercer JR; Wiebe LI; Wuest M; Moore RB
EJNMMI Res; 2014 Dec; 4(1):27. PubMed ID: 26116107
[TBL] [Abstract][Full Text] [Related]
14. A Comparative pO2 Probe and [18F]-Fluoro-Azomycinarabino-Furanoside ([18F]FAZA) PET Study Reveals Anesthesia-Induced Impairment of Oxygenation and Perfusion in Tumor and Muscle.
Mahling M; Fuchs K; Thaiss WM; Maier FC; Feger M; Bukala D; Harant M; Eichner M; Reutershan J; Lang F; Reischl G; Pichler BJ; Kneilling M
PLoS One; 2015; 10(4):e0124665. PubMed ID: 25902054
[TBL] [Abstract][Full Text] [Related]
15. 18F-FAZA PET imaging response tracks the reoxygenation of tumors in mice upon treatment with the mitochondrial complex I inhibitor BAY 87-2243.
Chang E; Liu H; Unterschemmann K; Ellinghaus P; Liu S; Gekeler V; Cheng Z; Berndorff D; Gambhir SS
Clin Cancer Res; 2015 Jan; 21(2):335-46. PubMed ID: 25381339
[TBL] [Abstract][Full Text] [Related]
16. A prospective clinical study of ¹⁸F-FAZA PET-CT hypoxia imaging in head and neck squamous cell carcinoma before and during radiation therapy.
Servagi-Vernat S; Differding S; Hanin FX; Labar D; Bol A; Lee JA; Grégoire V
Eur J Nucl Med Mol Imaging; 2014 Aug; 41(8):1544-52. PubMed ID: 24570097
[TBL] [Abstract][Full Text] [Related]
17. Validation of an engineered cell model for in vitro and in vivo HIF-1α evaluation by different imaging modalities.
Lo Dico A; Valtorta S; Martelli C; Belloli S; Gianelli U; Tosi D; Bosari S; Degrassi A; Russo M; Raccagni I; Lucignani G; Moresco RM; Ottobrini L
Mol Imaging Biol; 2014 Apr; 16(2):210-23. PubMed ID: 24002614
[TBL] [Abstract][Full Text] [Related]
18. [PET-MR in patients with glioblastoma multiforme].
Ertl-Wagner B; Ingrisch M; Niyazi M; Schnell O; Jansen N; Förster S; la Fougère C
Radiologe; 2013 Aug; 53(8):682-90. PubMed ID: 23949437
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic analysis of [18F]FAZA in non-small cell lung cancer patients.
Verwer EE; van Velden FH; Bahce I; Yaqub M; Schuit RC; Windhorst AD; Raijmakers P; Lammertsma AA; Smit EF; Boellaard R
Eur J Nucl Med Mol Imaging; 2013 Oct; 40(10):1523-31. PubMed ID: 23740374
[TBL] [Abstract][Full Text] [Related]
20. Highlighting the Versatility of the Tracerlab Synthesis Modules. Part 1: Fully Automated Production of [F]Labelled Radiopharmaceuticals using a Tracerlab FX(FN).
Shao X; Hoareau R; Hockley BG; Tluczek LJ; Henderson BD; Padgett HC; Scott PJ
J Labelled Comp Radiopharm; 2011 May; 54(6):292-307. PubMed ID: 21769163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
